This is one of the first papers on Biospecimen Management for the Community pathologist and therefore the community patient. In 2012, SpeciCare’s Chief of Pathology David Booker convened a group of academic pathologists including those from Mass General, Duke, NIH, and NCI. They then wrote about the biospecimen journey. They commented on how to handle the tumor of the individual cancer patient properly and on extending the value of the biospecimen to research and beyond the diagnosis and staging information obtained from the tumor placed in formalin and then embedded in paraffin. Few pathologists across the nation or world heeded these words, but this paper marks the early days of the now ten-year odyssey toward extraction of more value from the tumor biospecimen.
See the link below to read this paper.